SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-24-017836
Filing Date
2024-06-21
Accepted
2024-06-21 16:20:14
Documents
1
Period of Report
2024-06-20

Document Format Files

Seq Description Document Type Size
1 form4-06212024_040602.html 4  
1 form4-06212024_040602.xml 4 4004
  Complete submission text file 0001415889-24-017836.txt   5441
Mailing Address 1000 MARINA BLVD STE 200 BRISBANE CA 94005
Business Address
BERGER FRANKLIN M (Reporting) CIK: 0001273885 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38542 | Film No.: 241060686

Mailing Address 4000 SHORELINE COURT, SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 4000 SHORELINE COURT, SUITE 300 SOUTH SAN FRANCISCO CA 94080 650-822-5600
Kezar Life Sciences, Inc. (Issuer) CIK: 0001645666 (see all company filings)

IRS No.: 473366145 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)